Cargando…
Drug resistant tuberculosis in Africa: Current status, gaps and opportunities
BACKGROUND: The World Health Organization End TB Strategy targets for 2035 are ambitious and drug resistant tuberculosis is an important barrier, particularly in Africa, home to over a billion people. OBJECTIVE: We sought to review the current status of drug resistant tuberculosis in Africa and high...
Autores principales: | Ismail, Nazir, Ismail, Farzana, Omar, Shaheed V., Blows, Linsay, Gardee, Yasmin, Koornhof, Hendrik, Onyebujoh, Philip C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AOSIS
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295755/ https://www.ncbi.nlm.nih.gov/pubmed/30568900 http://dx.doi.org/10.4102/ajlm.v7i2.781 |
Ejemplares similares
-
Defining Bedaquiline Susceptibility, Resistance, Cross-Resistance and Associated Genetic Determinants: A Retrospective Cohort Study
por: Ismail, Nazir A., et al.
Publicado: (2018) -
Epidemiological cut-offs for Sensititre susceptibility testing of Mycobacterium tuberculosis: interpretive criteria cross validated with whole genome sequencing
por: Ismail, Nazir A., et al.
Publicado: (2020) -
Determining the risk-factors for molecular clustering of drug-resistant tuberculosis in South Africa
por: Said, Halima, et al.
Publicado: (2023) -
Distribution and Clonality of drug-resistant tuberculosis in South Africa
por: Said, Halima, et al.
Publicado: (2021) -
A Novel Molecular Strategy for Surveillance of Multidrug Resistant Tuberculosis in High Burden Settings
por: Said, Halima M., et al.
Publicado: (2016)